Clinical usefulness of serum angiotensin converting enzyme in silicosis

• Published in: Pulmonology Vol. 30; no. 4; pp. 370 - 377
• Main Authors: Blanco-Pérez, J., Salgado-Barreira, Á., Blanco-Dorado, S., González Bello, M.E., Caldera Díaz, A.C., Pérez-Gonzalez, A., Pallarés Sanmartín, A., Fernández Villar, A., Gonzalez-Barcala, F.J.
• Format: Journal Article
• Language: English
• Published: Spain Elsevier España, S.L.U 01.07.2024; Taylor & Francis
• Subjects: Internal Medicine; Pulmonary/Respiratory; Renin-angiotensin-aldosterone system; Serum Angiotensin-Converting Enzyme; Silicosis; ILD; MPF; ACE; sACE; ERS; RAAS; TLC; ILO; CT; FVC; DLCO; NIS; Serum Angiotensin-Converting Enzyme; Renin-angiotensin-aldosterone system; FEV1; SEPAR; Silicosis; COPD; Serum Angiotensin Converting Enzyme; Forced Expiratory Volume In One Second; European Respiratory Society; Carbon Monoxide Diffusing Capacity; Computed Tomography; Forced Vital Capacity; Angiotensin Converting Enzyme; Total Lung Capacity; International Labour Organization; Massive Progressive Fibrosis; Interstitial Lung Disease; Spanish Society of Chest Diseases and Thoracic Surgery; National Institute of Silicosis; Chronic Obstructive Pulmonary Disease

Silicosis is an irreversible and incurable disease. Preventive measures to eliminate exposure are the only effective way to reduce morbidity and mortality. In such situations, having a biomarker for early diagnosis or to predict evolution would be very useful in order to improve control of the disea...